These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25374889)

  • 1. The prognostic impact of high on-treatment platelet reactivity with aspirin or ADP receptor antagonists: systematic review and meta-analysis.
    D'Ascenzo F; Barbero U; Bisi M; Moretti C; Omedè P; Cerrato E; Quadri G; Conrotto F; Zoccai GB; DiNicolantonio JJ; Gasparini M; Bangalore S; Gaita F
    Biomed Res Int; 2014; 2014():610296. PubMed ID: 25374889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipstick proteinuria is an independent predictor of high on treatment platelet reactivity in patients on clopidogrel, but not aspirin, admitted for major adverse cardiovascular events.
    Davila CD; Vargas F; Huang KH; Monaco T; Dimou A; Rangaswami J; Figueredo VM
    Platelets; 2015; 26(7):651-6. PubMed ID: 25354134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin withdrawal in patients treated with ticagrelor presenting with non-ST elevation myocardial infarction.
    Beigel R; Mazin I; Koifman E; Shechter M; Pres H; Shlomo N; Rosenberg N; Asher E; Matetzky S
    J Thromb Haemost; 2018 Apr; 16(4):663-669. PubMed ID: 29443445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-related biomarkers and their response to inhibition with aspirin and p2y
    Lowenstern A; Storey RF; Neely M; Sun JL; Angiolillo DJ; Cannon CP; Himmelmann A; Huber K; James SK; Katus HA; Morais J; Siegbahn A; Steg PG; Wallentin L; Becker RC;
    J Thromb Thrombolysis; 2017 Aug; 44(2):145-153. PubMed ID: 28608165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of P2Y(1) receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel.
    Labarthe B; Babin J; Bryckaert M; Théroux P; Bonnefoy A
    Br J Pharmacol; 2012 May; 166(1):221-31. PubMed ID: 21950486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition.
    Badr Eslam R; Lang IM; Kaider A; Panzer S
    Transl Res; 2013 May; 161(5):414-20. PubMed ID: 23313628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of smoking on residual platelet reactivity to clopidogrel: a systematic review and meta-analysis.
    Liu Z; Xiang Q; Mu G; Xie Q; Zhou S; Wang Z; Chen S; Hu K; Gong Y; Jiang J; Cui Y
    Platelets; 2020; 31(1):3-14. PubMed ID: 30744477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does baseline hematocrit influence the assays of on-treatment platelet reactivity to clopidogrel?
    Pendyala LK; Loh JP; Lhermusier T; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Am Heart J; 2014 Oct; 168(4):545-51. PubMed ID: 25262265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
    Tantry US; Bonello L; Aradi D; Price MJ; Jeong YH; Angiolillo DJ; Stone GW; Curzen N; Geisler T; Ten Berg J; Kirtane A; Siller-Matula J; Mahla E; Becker RC; Bhatt DL; Waksman R; Rao SV; Alexopoulos D; Marcucci R; Reny JL; Trenk D; Sibbing D; Gurbel PA;
    J Am Coll Cardiol; 2013 Dec; 62(24):2261-73. PubMed ID: 24076493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High on-treatment platelet reactivity and outcomes after percutaneous endovascular procedures in patients with peripheral artery disease.
    Bernlochner I; Jaitner J; Fries V; Dommasch M; Mayer K; Ott I; Langwieser N; Fusaro M; Laugwitz KL; Kastrati A; Ibrahim T
    Vasa; 2016; 45(2):155-61. PubMed ID: 27058802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different prognostic significance of high on-treatment platelet reactivity as assessed by the VerifyNow P2Y12 assay after coronary stenting in patients with and without acute myocardial infarction.
    Ahn SG; Lee SH; Yoon JH; Kim WT; Lee JW; Youn YJ; Ahn MS; Kim JY; Yoo BS; Yoon J; Choe KH
    JACC Cardiovasc Interv; 2012 Mar; 5(3):259-67. PubMed ID: 22440490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of measured platelet reactivity with changes in P2Y
    Bagai A; Peterson ED; McCoy LA; Effron MB; Zettler ME; Stone GW; Henry TD; Cohen DJ; Schulte PJ; Anstrom KJ; Wang TY
    Am Heart J; 2017 May; 187():19-28. PubMed ID: 28454802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.
    Deharo P; Quilici J; Camoin-Jau L; Johnson TW; Bassez C; Bonnet G; Fernandez M; Ibrahim M; Suchon P; Verdier V; Fourcade L; Morange PE; Bonnet JL; Alessi MC; Cuisset T
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2560-2570. PubMed ID: 29268886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.
    Trenk D; Stone GW; Gawaz M; Kastrati A; Angiolillo DJ; Müller U; Richardt G; Jakubowski JA; Neumann FJ
    J Am Coll Cardiol; 2012 Jun; 59(24):2159-64. PubMed ID: 22520250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) study.
    Mangiacapra F; Patti G; Barbato E; Peace AJ; Ricottini E; Vizzi V; Gatto L; D'Ambrosio A; De Bruyne B; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2012 Mar; 5(3):281-9. PubMed ID: 22440493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin.
    Jeong YH; Tantry US; Kim IS; Koh JS; Kwon TJ; Park Y; Hwang SJ; Bliden KP; Kwak CH; Hwang JY; Gurbel PA
    Circ Cardiovasc Interv; 2011 Dec; 4(6):585-94. PubMed ID: 22045970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of aspirin dose on adenosine diphosphate-mediated platelet activities. Results of an in vitro pilot investigation.
    Tello-Montoliu A; Thano E; Rollini F; Patel R; Wilson RE; Muñiz-Lozano A; Franchi F; Darlington A; Desai B; Guzman LA; Bass TA; Angiolillo DJ
    Thromb Haemost; 2013 Oct; 110(4):777-84. PubMed ID: 23884248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of high on-treatment platelet reactivity in patients with chronic kidney disease treated with acetylsalicylic acid for stroke prevention.
    Horyniecki M; Łącka-Gaździk B; Niewiadomska E; Mazur B; Śnit M; Łabuz-Roszak B
    Pol Arch Intern Med; 2018 Nov; 128(11):667-676. PubMed ID: 30335048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuisance and alarming bleeding do not correlate with on-treatment platelet reactivity.
    Gaglia MA; Torguson R; Pokharel S; Pakala R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2013; 14(2):76-80. PubMed ID: 23375617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus.
    Valentine N; Van de Laar FA; van Driel ML
    Cochrane Database Syst Rev; 2012 Nov; 11():CD005449. PubMed ID: 23152231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.